At PrimaryMD, we find this grey zone intriguing but insist on balancing biological plausibility with data and safety
While it can be combined with IGF-1 LR3, youll need to monitor for IGF-1 overstimulation (e.g., lethargy, joint pain, insulin sensitivity shifts)
Lancet Diabetes Endocrinol 6(11):859869 Mann JFE, rsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S et al (2017) Liraglutide and renal outcomes in type 2 diabetes
Insights on Effective Medical Weight Loss by Kelli Marchewka With her expertise in weight management, Kelli Marchewka helps patients navigate the differences between Liraglutide, Semaglutide, and other GLP-1 treatments